ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,745.28
1.36%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Neoleukin Therapeutics Inc (NLTX)

  7. Neoleukin Therapeutics Inc (NLTX) Noticias

NLTX Neoleukin Therapeutics Inc

3.49
0.00 (0.00%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Neoleukin Therapeutics Inc NLTX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 3.49 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.49 3.49
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
26/4/202413:34EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26/4/202413:33EDGAR2Form ARS - Annual Report to Security Holders
26/4/202413:33EDGAR2Form DEF 14A - Other definitive proxy statements
22/4/202415:44EDGAR2Form 8-K - Current report
02/4/202414:43EDGAR2Form 8-K - Current report
18/3/202415:10EDGAR2Form 8-K - Current report
18/3/202415:04EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
14/3/202419:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/3/202419:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/3/202419:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:29EDGAR2Form 144 - Report of proposed sale of securities
04/3/202417:20EDGAR2Form 144 - Report of proposed sale of securities
04/3/202406:30EDGAR2Form 8-K - Current report
21/2/202415:07EDGAR2Form 8-K - Current report
20/2/202415:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/2/202417:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202415:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202414:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202408:19EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202415:18EDGAR2Form 144 - Report of proposed sale of securities
18/1/202418:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202417:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202417:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202417:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202417:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202417:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/1/202406:11EDGAR2Form 8-K - Current report
26/12/202317:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
26/12/202317:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
26/12/202317:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
26/12/202317:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
26/12/202317:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/12/202315:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
21/12/202315:05EDGAR2Form SC 13D - General statement of acquisition of beneficial..
19/12/202306:31EDGAR2Form 8-K - Current report
14/12/202318:00GLOBENeoleukin Therapeutics Announces 1-for-4 Reverse Stock Split
06/12/202315:24EDGAR2Form 425 - Prospectuses and communications, business..
06/12/202315:21EDGAR2Form 8-K - Current report
04/12/202316:14EDGAR2Form 425 - Prospectuses and communications, business..
04/12/202316:10EDGAR2Form 8-K - Current report
30/11/202315:06EDGAR2Form 425 - Prospectuses and communications, business..
08/11/202313:34EDGAR2Form S-4/A - Registration of securities, business..
18/10/202315:09EDGAR2Form S-4/A - Registration of securities, business..
05/10/202311:50EDGAR2Form 425 - Prospectuses and communications, business..
28/9/202315:28EDGAR2Form S-4/A - Registration of securities, business..
22/9/202307:03EDGAR2Form 8-K - Current report
22/9/202307:00GLOBENeoleukin Therapeutics Announces 1-for-5 Reverse Stock Split
14/8/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202315:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Su Consulta Reciente

NASDAQ
NLTX
Neoleukin Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados